Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract 4185: Targeting variant of CEACAM5 and CEACAM6 using NEO-201 and IL-15 in gynecologic cancers

Maria Pia Morelli, Massimo Fantini, Kwong Y. Tsang, Phillip Arlen, Paulette Fauceglia, Lidia Hernandez, Soumya Korrapati, Elijah Edmonson, Christopher Cole, Christina M. Annunziata

Cancer Res (2022) 82 (12_Supplement): 4185.

https://doi.org/10.1158/1538-7445.AM2022-4185

Published: 15 June 2022

View article titled, Abstract 4185: Targeting variant of CEACAM5 and CEACAM6 using NEO-201 and IL-15 in gynecologic cancers

Journal Articles

Abstract 4794: Mitochondrial matrix protease ClpP agonists inhibit cell growth and cancer stem cell function in breast cancer cells

Yoshimi E. Greer, Lidia Hernandez, Voeller Donna, Raj Chari, Sam Gilbert, Binwu Tang, Christina Annunziata, Lalage Wakefield, Edwin Iwanowicz, Lee M. Graves, Stanley Lipkowitz

Cancer Res (2020) 80 (16_Supplement): 4794.

https://doi.org/10.1158/1538-7445.AM2020-4794

Published: 15 August 2020

View article titled, Abstract 4794: Mitochondrial matrix protease ClpP agonists inhibit cell growth and cancer stem cell function in breast cancer cells

Journal Articles

NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH⁺ Cancer Stem–like Cells

Carrie D. House, Elizabeth Jordan, Lidia Hernandez, Michelle Ozaki, Jana M. James, Marianne Kim, Michael J. Kruhlak, Eric Batchelor, Fathi Elloumi, Margaret C. Cam, Christina M. Annunziata

Cancer Res (2017) 77 (24): 6927–6940.

https://doi.org/10.1158/0008-5472.CAN-17-0366

Published: 14 December 2017

View article titled, NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem–like Cells

Includes: Supplementary data

Journal Articles

Abstract 3025: Preclinical characterization of a novel monoclonal antibody targeting a neo-antigen expressed in ovarian and GI malignancies

Kristen Zeligs, Philip M. Arlen, Kwong Tsang, Lidia Hernandez, Massimo Fantini, Christina M. Annunziata

Cancer Res (2017) 77 (13_Supplement): 3025.

https://doi.org/10.1158/1538-7445.AM2017-3025

Published: 01 July 2017

View article titled, Abstract 3025: Preclinical characterization of a novel monoclonal antibody targeting a neo-antigen expressed in ovarian and GI malignancies

Journal Articles

SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2

Danielle F. Eytan, Grace E. Snow, Sophie Carlson, Adeeb Derakhshan, Anthony Saleh, Stephen Schiltz, Hui Cheng, Suresh Mohan, Shaleeka Cornelius, Jamie Coupar, Anastasia L. Sowers, Lidia Hernandez, James B. Mitchell, Christina M. Annunziata, Zhong Chen, Carter Van Waes

Cancer Res (2016) 76 (18): 5442–5454.

https://doi.org/10.1158/0008-5472.CAN-15-3317

Published: 15 September 2016

View article titled, SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2

Includes: Supplementary data

Journal Articles

Abstract 1496: Identification of target and cytotoxicity of novel monoclonal antibody NEO-201 in ovarian and uterine cancer subtypes

Monica K. Neuman, Lidia Hernandez, Xue-Ping Wang, Olga Saric, Alex Dubeykovskiy, Philip Arlen, Christina M. Annunziata

Cancer Res (2016) 76 (14_Supplement): 1496.

https://doi.org/10.1158/1538-7445.AM2016-1496

Published: 15 July 2016

View article titled, Abstract 1496: Identification of target and cytotoxicity of novel monoclonal antibody NEO-201 in ovarian and uterine cancer subtypes

Journal Articles

Abstract 4688: HPV+ cervical cancer cells are selectively killed by the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and the cyclin-dependent kinase-9 inhibitor (CDK9i) dinaciclib

David S. Kotlyar, Yoshimi E. Greer, Donna Voeller, Lidia Hernandez, Christina M. Annunziata, Stanley Lipkowitz

Cancer Res (2016) 76 (14_Supplement): 4688.

https://doi.org/10.1158/1538-7445.AM2016-4688

Published: 15 July 2016

View article titled, Abstract 4688: HPV+ cervical cancer cells are selectively killed by the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and the cyclin-dependent kinase-9 inhibitor (CDK9i) dinaciclib

Journal Articles

Abstract LB-254: High-throughput drug matrix screen with SMAC (second mitochondria-derived activator of caspases)-mimetic birinapant in high-grade serous ovarian cancer cell lines identifies synergism

Kristen Bunch, Ian Goldlust, Craig Thomas, Lidia Hernandez, Rajarshi Guha, Christina Annunziata

Cancer Res (2015) 75 (15_Supplement): LB-254.

https://doi.org/10.1158/1538-7445.AM2015-LB-254

Published: 01 August 2015

View article titled, Abstract LB-254: High-throughput drug matrix screen with SMAC (second mitochondria-derived activator of caspases)-mimetic birinapant in high-grade serous ovarian cancer cell lines identifies synergism

Journal Articles

IKK-ϵ Coordinates Invasion and Metastasis of Ovarian Cancer

Sarah Hsu, Marianne Kim, Lidia Hernandez, Valentina Grajales, Anne Noonan, Miriam Anver, Ben Davidson, Christina M. Annunziata

Cancer Res (2012) 72 (21): 5494–5504.

https://doi.org/10.1158/0008-5472.CAN-11-3993

Published: 31 October 2012

View article titled, IKK-ϵ Coordinates Invasion and Metastasis of Ovarian Cancer

Includes: Supplementary data

Journal Articles

Abstract 1479: IKK-epsilon contributes to the malignant progression of ovarian cancer

Christina M. Annunziata, Sarah Hsu, Lidia Hernandez, Elise Kohn, Ben Davidson

Cancer Res (2011) 71 (8_Supplement): 1479.

https://doi.org/10.1158/1538-7445.AM2011-1479

Published: 15 April 2011

View article titled, Abstract 1479: IKK-epsilon contributes to the malignant progression of ovarian cancer

Journal Articles

Activation of NF-κB Signaling by Inhibitor of NF-κB Kinase β Increases Aggressiveness of Ovarian Cancer

Lídia Hernandez, Sarah C. Hsu, Ben Davidson, Michael J. Birrer, Elise C. Kohn, Christina M. Annunziata

Cancer Res (2010) 70 (10): 4005–4014.

https://doi.org/10.1158/0008-5472.CAN-09-3912

Published: 12 May 2010

View article titled, Activation of NF-κB Signaling by Inhibitor of NF-κB Kinase β Increases Aggressiveness of Ovarian Cancer

Includes: Supplementary data

Journal Articles

Analysis of the extracellular matrix proteome by mass spectrometry

Zhen Xiao, Lidia Hernandez, Timothy Veenstra, Colin Stewart

Cancer Res (2007) 67 (9_Supplement): LB-306.

Published: 01 May 2007

View article titled, Analysis of the extracellular matrix proteome by mass spectrometry

Journal Articles

Mechanism of Action of Bisimidazoacridones, New Drugs with Potent, Selective Activity against Colon Cancer

Lidia Hernandez, Wieslaw M. Cholody, Eric A. Hudson, James H. Resau, Gary Pauly, Christopher J. Michejda

Cancer Res (1995) 55 (11): 2338–2345.

Published: 01 June 1995

View article titled, Mechanism of Action of Bisimidazoacridones, New Drugs with Potent, Selective Activity against Colon Cancer

Journal Articles

Activation of a β-Hydroxyalkylnitrosamine to Alkylating Agents: Evidence for the Involvement of a Sulfotransferase

Marilyn B. Kroeger-Koepke, Steven R. Koepke, Lidia Hernandez, Christopher J. Michejda

Cancer Res (1992) 52 (12): 3300–3305.

Published: 01 June 1992

View article titled, Activation of a β-Hydroxyalkylnitrosamine to Alkylating Agents: Evidence for the Involvement of a Sulfotransferase

Journal Articles

Enhancement of Hydroxylation and Deglycosylation of 2′-Deoxyguanosine by Carcinogenic Nickel Compounds

Kazimierz S. Kasprzak, Lidia Hernandez

Cancer Res (1989) 49 (21): 5964–5968.

Published: 01 November 1989

View article titled, Enhancement of Hydroxylation and Deglycosylation of 2′-Deoxyguanosine by Carcinogenic Nickel Compounds

NARROW

Abstract 4185: Targeting variant of CEACAM5 and CEACAM6 using NEO-201 and IL-15 in gynecologic cancers

Abstract 4794: Mitochondrial matrix protease ClpP agonists inhibit cell growth and cancer stem cell function in breast cancer cells

NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH⁺ Cancer Stem–like Cells

Abstract 3025: Preclinical characterization of a novel monoclonal antibody targeting a neo-antigen expressed in ovarian and GI malignancies

SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2

Abstract 1496: Identification of target and cytotoxicity of novel monoclonal antibody NEO-201 in ovarian and uterine cancer subtypes

Abstract 4688: HPV+ cervical cancer cells are selectively killed by the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and the cyclin-dependent kinase-9 inhibitor (CDK9i) dinaciclib

Abstract LB-254: High-throughput drug matrix screen with SMAC (second mitochondria-derived activator of caspases)-mimetic birinapant in high-grade serous ovarian cancer cell lines identifies synergism

IKK-ϵ Coordinates Invasion and Metastasis of Ovarian Cancer

Abstract 1479: IKK-epsilon contributes to the malignant progression of ovarian cancer

Activation of NF-κB Signaling by Inhibitor of NF-κB Kinase β Increases Aggressiveness of Ovarian Cancer

Analysis of the extracellular matrix proteome by mass spectrometry

Mechanism of Action of Bisimidazoacridones, New Drugs with Potent, Selective Activity against Colon Cancer

Activation of a β-Hydroxyalkylnitrosamine to Alkylating Agents: Evidence for the Involvement of a Sulfotransferase

Enhancement of Hydroxylation and Deglycosylation of 2′-Deoxyguanosine by Carcinogenic Nickel Compounds

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only